Bharat Bio trials went on despite adverse effect; experts worried

A participant in phase 1 clinical trials of the Covid vaccine being developed by Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR) fell ill and had to be hospitalised after taking the shot in July, but the trials were not halted and no public disclosure was made.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news